Selenium Supplementation Versus Placebo in Patients With Graves' Hyperthyroidism
Selenium Supplementation Versus Placebo in Patients With Graves' Hyperthyroidism
NCT ID: NCT01611896 Phase: NA Status: COMPLETED Enrollment: 431 Completion: 2024-08
Conditions
Graves' Hyperthyroidism
Interventions
Selenium, Placebo
Summary
The purpose of this study is to investigate if selenium supplementation to the standard treatment with anti-thyroid drugs in patients with Graves' hyperthyroidism, will lead to a fewer people with anti-thyroid treatment failure and faster remission, in terms of better quality of life during the first year of treatment and more patients staying in remission.
Primary Outcome
Proportion of participants with the composite outcome of 'ATD treatment failure'